Skip to content
My WebMD Sign In, Sign Up

Lung Cancer Health Center

Font Size
A
A
A

Summary of Evidence

Separate PDQ summaries on Lung Cancer Prevention, Small Cell Lung Cancer Treatment, Non-Small Cell Lung Cancer Treatment, and Levels of Evidence for Cancer Screening and Prevention Studies are also available.

Screening for Lung Cancer With Chest X-Ray and/or Sputum Cytology

Recommended Related to Lung Cancer

What Is Lung Cancer?

Although lung cancer is the leading cause of cancer death in the U.S. in both men and women, both the occurrence of lung cancer and the deaths related to it can be reduced. More than four out of every five cases of lung cancer are associated with cigarette smoking. The cause-and-effect relationship has been extensively documented. During the 1920s, large numbers of men began to smoke cigarettes, presumably in response to increased advertising. Twenty years later, the frequency of lung cancer in men...

Read the What Is Lung Cancer? article > >

Benefits

Based on fair evidence, screening does not reduce mortality from lung cancer.

Description of the Evidence

  • Study Design: Evidence obtained from randomized controlled trials.
  • Internal Validity: Fair, due to lack of unscreened groups and contamination.
  • Consistency: Good.
  • Direction and Magnitude of Effect: No evidence of effect.
  • External Validity: Fair, due to lack of women and minority groups.

Harms

Based on solid evidence, screening would lead to false-positive tests and unnecessary invasive diagnostic procedures and treatments.

Description of the Evidence

  • Study Design: Evidence obtained from randomized controlled trials.
  • Internal Validity: Fair.
  • Consistency: Good.
  • Direction and Magnitude of Effect: False-positive results range from 4% to 15%; there is a possibility of overdiagnosis and overtreatment (magnitude uncertain).
  • External Validity: Fair.

Screening for Lung Cancer With Low-Dose Helical Computed Tomography (LDCT)

Benefits

The evidence is inadequate to determine whether screening reduces mortality from lung cancer.

Description of the Evidence

  • Study Design: Evidence obtained from cohort or case-control studies.
  • Internal Validity: Poor for answering the question of mortality reduction from screening with LDCT.
  • Consistency: Good.
  • Direction and Magnitude of Effect: Cannot determine from the available studies.
  • External Validity: Not applicable; the internal validity of the evidence is poor.

Harms

Based on solid evidence, screening would lead to false-positive tests and unnecessary invasive diagnostic procedures and treatments.

Description of the Evidence

  • Study Design: Evidence obtained from cohort or case-control studies.
  • Internal Validity: Poor.
  • Consistency: Good.
  • Direction and Magnitude of Effect: False-positive results range from 20% to 50%; overdiagnosis and overtreatment are possible (magnitude uncertain).
  • External Validity: Fair.

WebMD Public Information from the National Cancer Institute

Last Updated: October 07, 2011
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.

Today in Lung Cancer

lung cancer overview slideshow
SLIDESHOW
what is your cancer risk
HEALTH CHECK
 
Using GPS to Detect Lung Cancer
VIDEO
mans hand putting out cigarette
Article
 
15 Cancer Symptoms Men Ignore
FEATURE
Lung Cancer Risks Myths and Facts
SLIDESHOW
 
cancer fighting foods
SLIDESHOW
Improving Lung Cancer Survival Targeted Therapy
VIDEO
 
Lung Cancer Surprising Differences Between Sexes
VIDEO
Pets Improve Your Health
SLIDESHOW
 
Vitamin D
SLIDESHOW
Lung Cancer Surgery Options
VIDEO
 

WebMD Special Sections